» Articles » PMID: 10782554

Development, Reliability and Acceptability of a New Version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to Assess Routine Social Functioning

Overview
Specialty Psychiatry
Date 2000 Apr 27
PMID 10782554
Citations 441
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Development of a scale to assess patients' social functioning, the Personal and Social Performance scale (PSP).

Method: PSP has been developed through focus groups and reliability studies on the basis of the social functioning component of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS). The last reliability study was carried out by 39 workers with different professional roles on a sample of 61 psychiatric patients admitted to the rehabilitation unit. Each patient was rated independently on the scale by the two workers who knew them best.

Results: The PSP is a 100-point single-item rating scale, subdivided into 10 equal intervals. The ratings are based mainly on the assessment of patient's functioning in four main areas: 1) socially useful activities; 2) personal and social relationships; 3) self-care; and 4) disturbing and aggressive behaviours. Operational criteria to rate the levels of disabilities have been defined for the above-mentioned areas. Excellent inter-rater reliability was also obtained in less educated workers.

Conclusion: Compared to SOFAS, PSP has better face validity and psychometric properties. It was found to be an acceptable, quick and valid measure of patients' personal and social functioning.

Citing Articles

Dynamics of Clinical Manifestations and Social Functioning in Schizophrenia: A Non-interventional Observational Study of Paliperidone Palmitat Dosage Forms.

Reznik A, Karpenko O, Shumakova E, Mudrak A, Sokolov A, Nazimova S Consort Psychiatr. 2025; 5(4):16-38.

PMID: 39980622 PMC: 11839220. DOI: 10.17816/CP15567.


Association between Adverse Childhood Experiences and long-term outcomes in people at Clinical High-Risk for Psychosis.

Tognin S, Catalan A, Aymerich C, Richter A, Kempton M, Modinos G Schizophrenia (Heidelb). 2025; 11(1):23.

PMID: 39979326 PMC: 11842736. DOI: 10.1038/s41537-025-00562-9.


Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section.

Minichino A, Davies C, Karpenko O, Christodoulou N, Ramalho R, Nandha S Mol Psychiatry. 2025; .

PMID: 39953286 DOI: 10.1038/s41380-025-02902-8.


Machine learning-based prediction of antipsychotic efficacy from brain gray matter structure in drug-naive first-episode schizophrenia.

Guo X, Zhou E, Wang X, Huang B, Gao T, Pu C Schizophrenia (Heidelb). 2025; 11(1):11.

PMID: 39893207 PMC: 11787389. DOI: 10.1038/s41537-025-00557-6.


Predictors of Psychosocial Functioning Among Long-stay Schizophrenia Patients in a Malaysian Mental Institution.

Teo P, Koh E, Chong S Malays J Med Sci. 2025; 31(6):178-193.

PMID: 39830103 PMC: 11740817. DOI: 10.21315/mjms2024.31.6.14.